Literature DB >> 5415673

Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases.

R D Wochner.   

Abstract

The metabolism of radioiodinated IgG was studied in a series of 42 patients with connective tissue diseases (16 systemic lupus erythematosus, nine rheumatoid arthritis, five polymyositis, five vasculitis, and seven miscellaneous diagnoses). Fractional catabolic rates were increased and survival half-lives were shortened in all diagnostic categories indicating hypercatabolism of IgG. This hypercatabolism was masked by increased IgG synthesis, resulting in elevated serum concentrations of IgG in patients with systemic lupus erythematosus and rheumatoid arthritis and in generally normal concentrations in the others. The metabolism of iodinated IgM was also studied in eight patients with systemic lupus erythematosus, in seven with rheumatoid arthritis, and in 12 controls. The fractional catabolic rates were normal in both groups of patients. Serum concentrations of both IgM and IgA were moderately elevated in all diagnostic categories. Serum albumin metabolism was entirely normal in the nine subjects studied who were not receiving corticosteroids; in three who were receiving them, moderate hypercatabolism was observed. The hypercatabolism of IgG could not be accounted for by factors previously known to alter IgG metabolism. It was not observed in 15 patients with other chronic, inflammatory diseases and was not explained by concomitant administration of adrenal corticosteroids to some patients. Identical results were obtained whether the IgG was obtained from a patient himself or from a normal donor, demonstrating that the hypercatabolism is a host defect and not an abnormality of the protein. Thus, patients with connective tissue disease of several different diagnostic categories have been shown to have an unexplained immunoglobulin abnormality: they catabolize normal IgG at an accelerated rate.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5415673      PMCID: PMC322492          DOI: 10.1172/JCI106254

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION.

Authors:  J L FAHEY; A G ROBINSON
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

2.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

3.  THE EFFECT OF CUSHING'S SYNDROME UPON SERUM ALBUMIN METABOLISM.

Authors:  K Sterling
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

Review 4.  Immune-complex disease.

Authors:  C L Christian
Journal:  N Engl J Med       Date:  1969-04-17       Impact factor: 91.245

5.  Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss.

Authors:  R D Wochner; S M Weissman; T A Waldmann; D Houston; N I Berlin
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

6.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Studies of cryoproteins in systemic lupus erythematosus.

Authors:  L B Hanauer; C L Christian
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

8.  Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors:  C Krishnan; M H Kaplan
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  The distribution of I131 labeled human serum albumin introduced into ascitic fluid: analysis of the kinetics of a three compartment catenary transfer system in man and speculations on possible sites of degradation.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  12 in total

1.  Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin.

Authors:  T A Waldmann; W D Terry
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Metabolism of autologous and homologous IgG in rheumatoid arthritis.

Authors:  M A Catalano; E H Krick; D H De Heer; R M Nakamura; A N Theofilopoulos; J H Vaughan
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  Metabolism of radio-iodinated IgG in patients with abnormal serum IgG levels. II. Hypogamma-globulinaemia.

Authors:  J V Wells; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

4.  Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study.

Authors:  W Glinz; P J Grob; U E Nydegger; T Ricklin; F Stamm; D Stoffel; A Lasance
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

5.  Metabolism of radio-iodinated IgG in patients with abnormal IgG levels. I. Hypergamma-globulinaemia.

Authors:  J V Wells; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

6.  The effect of azathioprine on gammaglobulin synthesis in man.

Authors:  J Levy; E V Barnett; N S MacDonald; J R Klinenberg; C M Pearson
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

7.  Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar rates.

Authors:  J A Schifferli; N Amos; C D Pusey; J G Sissons; D K Peters
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

Review 8.  Clearance of cryoglobulins in man.

Authors:  Y C Ng; J A Schifferli
Journal:  Springer Semin Immunopathol       Date:  1988

Review 9.  Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.

Authors:  Veena A Thomas; Joseph P Balthasar
Journal:  Antibodies (Basel)       Date:  2019-12-04

10.  In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart.

Authors:  Francis Man; Alexander Koers; Panagiotis Karagiannis; Debra H Josephs; Heather J Bax; Amy E Gilbert; Tihomir S Dodev; Silvia Mele; Giulia Chiarruttini; Silvia Crescioli; Jitesh Chauhan; Julia E Blower; Margaret S Cooper; James Spicer; Sophia N Karagiannis; Philip J Blower
Journal:  Oncoimmunology       Date:  2021-09-06       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.